AzTrials
AzTrials

Soft Tissue AugmentationNCT07434297

Pontic Site Soft Tissue Augmentation Using De-epithelized Connective Tissue Graft Versus Partially De-epithelized Connective Tissue Graft

A study testing Intervention in people with Soft Tissue Augmentation and Pontic Site Development, run by October University for Modern Sciences and Arts at 1 site in Egypt.

Completed

Finished. The study has ended and is not enrolling. Results may be posted on the official record.

Official record
Search all trials

Trial summary

a comparative study to evaluate the pontic site soft tissue augmentation by partially de-epithelized connective tissue graft versus completely de-epithelized connective tissue graft (both grafts harvested from the hard palate). Read more about this study

Who is it for?
Ages 20 to 45 yearsHealthy volunteers can take part
What is being tested?
Intervention
Type of treatment
Surgery or procedure
Could I receive a placebo?
No, everyone receives an active treatment
How many people
24 participants
Where
1 siteEgypt
Study dates
20 Dec 2024to 2 Feb 2026
Phase
Interventional
Are there results?
None posted in the registry

Key requirements

Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.

  • Ages 20 to 45 years
  • All sexes
  • Healthy volunteers accepted
  • Adult

Who may be able to join

  • age 20-45 years
  • medically free
  • bounded missing teeth
  • patient accepting the fixed prosthetics as a treatment option
  • restorable adjacent abutments
  • periodontally healthy adjacent abutments
  • motivated patient to have the treatment
  • bleeding and plaque index less than 20%

Who cannot join

  • systemic diseases
  • smoking
  • pregnancy
  • patients with pervious soft tissue grafting

Trial locations and contacts

1 site in 1 country.

Egypt1 site
  • Modern Sciences and Arts University

    Giza

Other trials in Egypt

About this study

Official title: Assessment of Soft Tissue Profile After Pontic Site Development Using De-Epithelized Connective Tissue Graft Versus Partially De-Epithelized Connective Tissue Graft: A Randomized Controlled Clinical Trial.

a comparative study to evaluate the pontic site soft tissue augmentation by partially de-epithelized connective tissue graft versus completely de-epithelized connective tissue graft (both grafts harvested from the hard palate). pontic site soft tissue augmentation allows the correction of soft tissue to allow proper fixed dental bridge fabrication (for esthetic and functional purposes)

Being tested
Intervention, Control

What participants receive

What participants receive. In a randomised study each person is assigned to one group by chance.

  • InterventionProcedure or surgery

    de-epithelized connective tissue graft for soft tissue augmentation for pontic site development

  • ControlProcedure or surgery

    partially de-epithelized connective tissue graft for soft tissue grafting for pontic site development

Study groups in NCT07434297
Study groupRoleWhat they receive
intervention (using autogenous de-epithelized connective tissue graft for pontic site)Otherintervention (using autogenous de-epithelized connective tissue graft for pontic site soft tissue augmentation
Receives: Procedure: Intervention
control group ( partially De-Epithelized connective tissue graft )Othercontrol group ( partially autogenous De-Epithelized connective tissue graft )
Receives: Procedure: Control

What is being measured

The primary outcome is the main question the study is designed to answer.

  1. keratinized tissue thickness

    Measured: time of enrollment, 3 and 6 months postoperative

Secondary outcomes (2)
  1. soft tissue healing index

    Measured: 6 months postoperative

  2. Pain score

    Measured: 3 and 7 days postoperative

Timeline

From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.

  1. First posted25 Feb 2026
  2. Study start20 Dec 2024
  3. Primary completion1 Feb 2026
  4. Study completion2 Feb 2026

Resources

More details

For doctors and researchers: how the study is designed, who runs it, and its registry IDs.

Study design
Study type
Interventional
Phase
Phase N/A
Primary purpose
Treatment
Allocation
Randomised
Intervention model
Parallel groups
Masking
Triple blind
Who is masked
Participant, Investigator, Outcomes assessor
Enrolment
24 participants (actual)
IDs, dates and publications
ClinicalTrials.gov ID
NCT07434297
Sponsor's protocol ID
9.1.1
Status last verified
Jan 2025
First submitted
12 Jan 2026
Last updated
25 Feb 2026
Results posted
No
Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
Individual data sharing
Undecided

Questions about this trial

What is this clinical trial studying?

A study testing Intervention in people with Soft Tissue Augmentation and Pontic Site Development, run by October University for Modern Sciences and Arts at 1 site in Egypt.

The full registered description is in the About this study section and the official record.

Who may be eligible to take part?

The sponsor lists 8 inclusion and 4 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.

Is this clinical trial currently recruiting?

The record says: finished, as of the sponsor's last update on 25 Feb 2026. Status can change between updates, so confirm with the study contact before making plans.

Where is the study taking place?

The record lists 1 site in Egypt. Whether a site is taking part right now should be confirmed with that site. See every site.

What are the possible benefits and risks?

They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.

Are results available for this study?

The study is completed, but results are not available in the source record. That does not mean the treatment did or did not work.

How can a doctor refer a patient or contact the research team?

The record lists no contact. The official record names the sponsor, who can be asked directly. AzTrials does not enrol participants or take referrals.

What does the primary outcome measure?

keratinized tissue thickness (time frame: time of enrollment, 3 and 6 months postoperative). It is what the study was designed to measure, not a finding.

Where can I read the original study information?
Does a listing mean the treatment is approved or proven to work?

No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.

How often is this information updated?

AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 25 Feb 2026.

Free account

Keep searching with a free account

You’ve used your 3 free searches for this session. Log in or create a free AzTrials account to keep searching clinical trials and save the ones you want to follow.

Create a free accountLog in